| Literature DB >> 28367526 |
Reza Karkhaneh1, Masoud Nikbakht1, Fatemeh Bazvand1, Afshin Kalantary Oskouei1, Hamed Ghasemi1, Fariba Ghassemi1.
Abstract
PURPOSE: To measure the submacular choroidal thickness in eyes with idiopathic macular hole (IMH) compared with unaffected fellow eyes and normal control eyes.Entities:
Keywords: Choroidal thickness; Idiopathic macular hole; Macular hole
Year: 2016 PMID: 28367526 PMCID: PMC5362387 DOI: 10.1016/j.joco.2016.08.005
Source DB: PubMed Journal: J Curr Ophthalmol ISSN: 2452-2325
Fig. 1A. Measurement of choroidal thickness at the fovea and 1 mm and 2 mm away from the fovea in the nasal and temporal directions. The green line refers to the apical diameter of the macular hole, and the blue line refers to the basal macular hole. B. The measurement of choroidal thicknesses at the fovea, 1 mm, and 2 mm from the foveal center in the contralateral eye of the same patient.
Baseline characteristics of idiopathic macular hole (IMH) and control groups.
| Group A (no of eyes = 41) | Group C (no of eyes = 30) | P Value | |
|---|---|---|---|
| Age (years) | 65.4 ± 6.38 | 66.5 ± 7.80 | 0.86 |
| Gender (male/female) | 18/23 | 15/15 | 0.94 |
| Refractive error (SE) | −0.49 ± 1.94 | −0.39 ± 1.74 | 0.65 |
| Axial length (mm) | 23.18 ± 0.88 | 23.3 ± 0.87 | 0.83 |
NA: not assessed, No: number, SE: spherical equivalent. The affected eyes with IMH (group A) and the normal control eyes (group C).
Mean choroidal thickness at five locations in the idiopathic macular hole (IMH), bilateral IMH excluded, normal fellow eyes, and the normal control eyes.
| Mean choroidal thickness ± SD (μm) | P Value (mean deviation, Kruskal–Wallis) | |||||||
|---|---|---|---|---|---|---|---|---|
| Group A (no of eyes = 41) | Group A1 (no of eyes = 23) | Group B (no of eyes = 23) | Group C (no of eyes = 30) | A-C | A-B | B-C | A1-B | |
| SFCT | 215.76 ± 66.7 | 221.64 ± 79.9 | 231.79 ± 68.6 | 288.53 ± 72.0 | 0.000* | 0.000* (−72.76) | 0.018* (−56.7) | 0.81 (−10.14) |
| N0.5 | 201.34 ± 59.3 | 203.01 ± 68.2 | 212.6 ± 66.2 | 272.05 ± 74.6 | 0.000* | 0.000* (−70.71) | 0.008* (−59.45) | 0.75 (−9.59) |
| N1 | 185.63 ± 55.3 | 184.94 ± 64.0 | 201.1 ± 63.0 | 250.97 ± 67.6 | 0.000* | 0.000* (−65.33) | 0.023* (−49.86) | 0.6 (−16.15) |
| N2 | 146.98 ± 50.5 | 145.78 ± 60.4 | 159.17 ± 59.3 | 194.02 ± 59.9 | 0.008* | 0.004* (−47.03) | 0.151 (−34.84) | 0.52 (−13.39) |
| T0.5 | 215.89 ± 61.9 | 218.36 ± 73.1 | 231.16 ± 61.0 | 285.03 ± 68.9 | 0.000* | 0.000* (−69.14) | 0.015* (−53.87) | 0.92 (−12.8) |
| T1 | 211.41 ± 57.1 | 214.57 ± 67.9 | 229.65 ± 57.8 | 275.36 ± 60.8 | 0.000* | 0.000* (−63.95) | 0.033* (−47.71) | 0.71 (−15.07) |
| T2 | 206.79 ± 50.1 | 215.86 ± 59.34 | 213.68 ± 53.7 | 251.26 ± 51.3 | 0.003* | 0.003* (−44.46) | 0.055 (−37.57) | 0.85 (2.17) |
IMH: idiopathic macular hole, SD: standard deviation, No: number, *: significant, SFCT: sub foveal choroidal thickness, N: nasal, T: temporal, 0.5: 0.5 mm from the fovea, 1: 1 mm from the fovea, 2: 2 mm from the fovea. The affected eyes with IMH (group A), the normal fellow eyes of patients (group B), and the normal eyes of healthy subjects as control samples (group C).
Mean choroidal thickness and best corrected visual acuity at five locations in the idiopathic macular hole (IMH), pre- and post-vitrectomy.
| Mean choroidal thickness ± SD (μm) | P Value | ||
|---|---|---|---|
| Group A (pre operation) No of eyes = 12 | Group D (post operation) No of eyes = 12 | ||
| SFCT | 225.89 ± 49.4 | 224.3 ± 49.9 | 0.95 |
| N0.5 | 217.03 ± 50.7 | 216.62 ± 51.3 | 0.91 |
| N1 | 198.08 ± 56.5 | 198.52 ± 55.9 | 0.92 |
| N2 | 155.96 ± 48.7 | 152.69 ± 50.9 | 0.91 |
| T0.5 | 228.98 ± 50.1 | 227.09 ± 48.9 | 0.92 |
| T1 | 228.08 ± 56.4 | 227.94 ± 54.8 | 0.82 |
| T2 | 213.94 ± 51.5 | 214.55 ± 48.2 | 0.77 |
| BCVA | 0.95 ± 0.38 | 0.55 ± 0.18 | 0.123 |
SD: standard deviation, No: number, BCVA: best corrected visual acuity, SFCT: sub foveal choroidal thickness, N: nasal, T: temporal, 0.5: 0.5 mm from the fovea, 1: 1 mm from the fovea, 2: 2 mm from the fovea. The affected eyes with IMH (group A) and the eyes after surgery (group D).
Correlation between mean choroidal thickness and age at five locations in the idiopathic macular hole (IMH), normal fellow eyes, and control eyes.
| Group A (no of eyes = 41) | Group B (no of eyes = 23) | Group C (no of eyes = 30) | |
|---|---|---|---|
| SFCT | P = 0.001 | P = 0.006 | P = 0.005 |
| r = −0.48 | r = −0.55 | r = −0.49 | |
| N0.5 mm | P = 0.001 | P = 0.007 | P = 0.003 |
| r = −0.48 | r = −0.548 | r = −0.51 | |
| N1 mm | P = 0.006 | P = 0.008 | P = 0.004 |
| r = −0.42 | r = −0.542 | r = −0.50 | |
| N2 mm | P = 0.001 | P = 0.012 | P = 0.001 |
| r = −0.48 | r = −0.51 | r = −0.58 | |
| T0.5 mm | P = 0.000 | P = 0.014 | P = 0.013 |
| r = −0.53 | r = −0.50 | r = −0.44 | |
| T1 mm | P = 0.001 | P = 0.004 | P = 0.006 |
| r = −0.50 | r = −0.57 | r = −0.48 | |
| T2 mm | P = 0.009 | P = 0.003 | P = 0.124 |
| r = −0.40 | r = −0.58 | r = −0.27 |
No: number, SFCT: sub foveal choroidal thickness, N: nasal, T: temporal, 0.5: 0.5 mm from the fovea, 1: 1 mm from the fovea, 2: 2 mm from the fovea. The affected eyes with IMH (group A), the normal fellow eyes of patients (group B), and the normal eyes of healthy subjects as control samples (group C).
The results of several studies about choroidal thickness and macular hole.
| Study | Sample size (patients) | Study year | Age(y) | SFCT in affected eye (μm) (1) | SFCT in fellow eye (μm) (2) | SFCT in normal eye (μm) (3) | Post operative (μm) (4) | P Value |
|---|---|---|---|---|---|---|---|---|
| Reibaldi et al | 22 | 2011 | 68 | 183 | 196 | 245 | – | NS/<0.01/NA |
| Zeng et al | 50 | 2012 | 63 | 206 | 228 | 248.88 | – | 0.177/0.002/NA |
| Fujiwara et al | 40 | 2012 | 68.9 | 182 | – | – | 187 at 3 m | NA/NA/NS |
| Schaal et al | 12 | 2012 | – | 274 | 268 | – | 276 at 6 m | NA/NA/NS |
| Xu et al | 19 | 2015 | 65 | 215 | 197 | 262 | – | 0.0013/NA |
| Present study | 34 | 2015 | 66 | 215 | 231 | 288 | 224 at 4.5 m | 0.000/0.000/0.95 |
Y: year, SFCT: sub foveal choroidal thickness, vs.: versus, NS: not significant, NA: not available, m: month. μm: micrometer.